
Hyderabad team targets fungus's sugar pathway to fight resistance
The story in brief
Hyderabad researchers developed a strategy to combat drug-resistant fungal infections by targeting glycolysis in Candida albicans. The study found compounds that block the fungus's ability to transform into invasive filaments, with one compound increasing sensitivity to fluconazole and amphotericin B. The research highlights pyruvate kinase as a key metabolic node.